260 related articles for article (PubMed ID: 21504425)
21. Recurrent de novo mutations of SCN1A in severe myoclonic epilepsy of infancy.
Kearney JA; Wiste AK; Stephani U; Trudeau MM; Siegel A; RamachandranNair R; Elterman RD; Muhle H; Reinsdorf J; Shields WD; Meisler MH; Escayg A
Pediatr Neurol; 2006 Feb; 34(2):116-20. PubMed ID: 16458823
[TBL] [Abstract][Full Text] [Related]
22. Cryptogenic epileptic syndromes related to SCN1A: twelve novel mutations identified.
Zucca C; Redaelli F; Epifanio R; Zanotta N; Romeo A; Lodi M; Veggiotti P; Airoldi G; Panzeri C; Romaniello R; De Polo G; Bonanni P; Cardinali S; Baschirotto C; Martorell L; Borgatti R; Bresolin N; Bassi MT
Arch Neurol; 2008 Apr; 65(4):489-94. PubMed ID: 18413471
[TBL] [Abstract][Full Text] [Related]
23. Dravet syndrome history.
Dravet C
Dev Med Child Neurol; 2011 Apr; 53 Suppl 2():1-6. PubMed ID: 21504424
[TBL] [Abstract][Full Text] [Related]
24. A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome.
Tro-Baumann B; von Spiczak S; Lotte J; Bast T; Haberlandt E; Sassen R; Freund A; Leiz S; Stephani U; Boor R; Holthausen H; Helbig I; Kluger G
Epilepsia; 2011 Jan; 52(1):175-8. PubMed ID: 21219303
[TBL] [Abstract][Full Text] [Related]
25. Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study.
McIntosh AM; McMahon J; Dibbens LM; Iona X; Mulley JC; Scheffer IE; Berkovic SF
Lancet Neurol; 2010 Jun; 9(6):592-8. PubMed ID: 20447868
[TBL] [Abstract][Full Text] [Related]
26. A case of SUDEP in a patient with Dravet syndrome with SCN1A mutation.
Le Gal F; Korff CM; Monso-Hinard C; Mund MT; Morris M; Malafosse A; Schmitt-Mechelke T
Epilepsia; 2010 Sep; 51(9):1915-8. PubMed ID: 20738378
[TBL] [Abstract][Full Text] [Related]
27. Mosaicism of a missense SCN1A mutation and Dravet syndrome in a Roma/Gypsy family.
Azmanov DN; Zhelyazkova S; Dimova PS; Radionova M; Bojinova V; Florez L; Smith SJ; Tournev I; Jablensky A; Mulley J; Scheffer I; Kalaydjieva L; Sander JW
Epileptic Disord; 2010 Jun; 12(2):117-24. PubMed ID: 20562086
[TBL] [Abstract][Full Text] [Related]
28. Dravet syndrome and SCN1A gene mutation related-epilepsies: cognitive impairment and its determinants.
Guerrini R; Falchi M
Dev Med Child Neurol; 2011 Apr; 53 Suppl 2():11-5. PubMed ID: 21504426
[TBL] [Abstract][Full Text] [Related]
29. SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features.
Selmer KK; Lund C; Brandal K; Undlien DE; Brodtkorb E
Epilepsy Behav; 2009 Nov; 16(3):555-7. PubMed ID: 19782004
[TBL] [Abstract][Full Text] [Related]
30. Borderline Dravet syndrome: a useful diagnostic category?
Guerrini R; Oguni H
Epilepsia; 2011 Apr; 52 Suppl 2():10-2. PubMed ID: 21463273
[TBL] [Abstract][Full Text] [Related]
31. Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity.
Gennaro E; Veggiotti P; Malacarne M; Madia F; Cecconi M; Cardinali S; Cassetti A; Cecconi I; Bertini E; Bianchi A; Gobbi G; Zara F
Epileptic Disord; 2003 Mar; 5(1):21-5. PubMed ID: 12773292
[TBL] [Abstract][Full Text] [Related]
32. A screening test for the prediction of Dravet syndrome before one year of age.
Hattori J; Ouchida M; Ono J; Miyake S; Maniwa S; Mimaki N; Ohtsuka Y; Ohmori I
Epilepsia; 2008 Apr; 49(4):626-33. PubMed ID: 18076640
[TBL] [Abstract][Full Text] [Related]
33. The core Dravet syndrome phenotype.
Dravet C
Epilepsia; 2011 Apr; 52 Suppl 2():3-9. PubMed ID: 21463272
[TBL] [Abstract][Full Text] [Related]
34. Variable epilepsy phenotypes associated with a familial intragenic deletion of the SCN1A gene.
Guerrini R; Cellini E; Mei D; Metitieri T; Petrelli C; Pucatti D; Marini C; Zamponi N
Epilepsia; 2010 Dec; 51(12):2474-7. PubMed ID: 21204810
[TBL] [Abstract][Full Text] [Related]
35. Epilepsy with a de novo missense mutation in the sodium channel a1 subunit: a case report.
Stefanaki E; Aggelakou V; Orfanou M; Kokori E; Boutoufianakis S
Acta Paediatr; 2006 Dec; 95(12):1703-6. PubMed ID: 17129991
[TBL] [Abstract][Full Text] [Related]
36. Acute encephalopathy in a patient with Dravet syndrome.
Tsuji M; Mazaki E; Ogiwara I; Wada T; Iai M; Okumura A; Yamashita S; Yamakawa K; Osaka H
Neuropediatrics; 2011 Feb; 42(2):78-81. PubMed ID: 21647847
[TBL] [Abstract][Full Text] [Related]
37. Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome.
Kwong AK; Fung CW; Chan SY; Wong VC
PLoS One; 2012; 7(7):e41802. PubMed ID: 22848613
[TBL] [Abstract][Full Text] [Related]
38. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome.
Brunklaus A; Ellis R; Reavey E; Forbes GH; Zuberi SM
Brain; 2012 Aug; 135(Pt 8):2329-36. PubMed ID: 22719002
[TBL] [Abstract][Full Text] [Related]
39. The spectrum of SCN1A-related infantile epileptic encephalopathies.
Harkin LA; McMahon JM; Iona X; Dibbens L; Pelekanos JT; Zuberi SM; Sadleir LG; Andermann E; Gill D; Farrell K; Connolly M; Stanley T; Harbord M; Andermann F; Wang J; Batish SD; Jones JG; Seltzer WK; Gardner A; ; Sutherland G; Berkovic SF; Mulley JC; Scheffer IE
Brain; 2007 Mar; 130(Pt 3):843-52. PubMed ID: 17347258
[TBL] [Abstract][Full Text] [Related]
40. Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome.
Lotte J; Haberlandt E; Neubauer B; Staudt M; Kluger GJ
Neuropediatrics; 2012 Feb; 43(1):17-21. PubMed ID: 22430156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
